Sunday, August 7, 2022


Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery

Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation,...

Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company completed the enrollment of 121 patients...

Radiopharm Enters Into Collaboration With Lantheus and Assumes PD-L1 Agreement

Radiopharm Theranostics, a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce that it has...

Antengene Announces First Patient Dosed in the PROBE-CN Study of ATG-101

Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...

Genkore Develops Hypercompact Base Editing System

GenKOre (homepage:, a biotech start-up in Korea, had a study on the development of hypercompact adenine base editors (ABEs) published on Nature Chemical...

Hot Topics